M. Miles Braun - Concepedia

Author

M. Miles Braun

Center for Biologics Evaluation and Research

Also Known As

E Shultz, M Braun, M M Braun, M Miles Braun, M. Braun, M. M. Braun, M. MILES BRAUN, M. MILES. BRAUN, M. Miles Braun, M.M. Braun

100

Publications

11.5K

Citations

H-Index

Concepts

All Affiliations

Center for Biologics Evaluation and Research Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases United States Food and Drug Administration Johns Hopkins University

About

M. Miles Braun is an author at Center for Biologics Evaluation and Research specializing in medicine, vaccination, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	23	1.9K
2	Public Health	8	8	591
3	Engineering	2	2	36
4	Allergy	2	2	315
5	Allergy Medicine	1	1	289

M. Miles Braun

Publications

9.8K

Citations

H-Index

Page 1

	Year	Citations
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent Joseph Keane, Sharon K. Gershon, Robert P. Wise, New England Journal of Medicine	2001	3.7K
Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration S Brown, Mark H. Greene, Sharon K. Gershon, Arthritis & Rheumatism	2002	661
Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept Jong‐Hoon Lee, Nancy R. Slifman, Sharon K. Gershon, Arthritis & Rheumatism	2002	448
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. Weigong Zhou, Vitali Pool, John K. Iskander, PubMed	2003	397
<i>Listeria monocytogenes</i> infection as a complication of treatment with tumor necrosis factor α–neutralizing agents Nancy R. Slifman, Sharon K. Gershon, Jong‐Hoon Lee, Arthritis & Rheumatism	2003	387
Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases Timothy R. Coté, Aparna Mohan, Jacquelyn A. Polder, Journal of the American Academy of Dermatology Adverse EventsBotulinum Toxin TypeDermatologyMedicineUs Food	2005	355
Risk of Anaphylaxis After Vaccination of Children and Adolescents Kari Bohlke, Robert L. Davis, S. Michael Marcy, PEDIATRICS	2003	321
Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor Inhibitor Ankith Mohan, Ronald Timothy, Joel A. Block, Clinical Infectious Diseases	2004	303
Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization Kari Bohlke, Robert L. Davis, Frank DeStefano, Journal of Allergy and Clinical Immunology Environmental AllergyAllergyAdolescent MedicinePediatric EpidemiologyAllergy Medicine	2004	289
Adverse event reports following yellow fever vaccination Nicole P. Lindsey, Betsy Schroeder, Elaine R. Miller, Vaccine VaccinationDisease OutbreakYellow Fever VaccinationInfection ControlMedicine	2008	277

Page 1